n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, May 8th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Alliance BioEnergy Plus, Inc. (ALLM)

Stocks That Move reported previously on Alliance BioEnergy Plus, Inc. (ALLM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alliance BioEnergy Plus, Inc. concentrates on the commercialization and licensing of a patented cellulose conversion technology. It controls this technology via a master license agreement with the University of Central Florida. Alliance BioEnergy Plus’s subsidiaries focus on developing technologies in the renewable energy, bio-fuels, and new technologies sectors. Alliance BioEnergy Plus is headquartered in West Palm Beach, Florida.

The Company operates various subsidiaries. AMG Energy Group, LLC owns 50 percent of Carbolosic, LLC (in a joint venture with Thor Renewable Energy Singapore) and exclusively the territories of North America and Africa. Carbolosic holds the exclusive global license for the patented CTS™ (Cellulose to Sugar) process, developed and owned by the University of Central Florida. The CTS™ process converts cellulose into commercial grade sugars, fine chemicals and other highly valuable products.  Alliance BioEnergy Plus’s intention is to concentrate on the production of these commercial products via company-owned and licensed facilities.

Alliance’s commercial pilot/demonstration and research facility, Ek Laboratories, LLC, came online in early 2015.  Under the direction of CTS™ inventor Dr. Richard Blair, the facility is running the CTS process, at a commercial scale, and is providing licensees with real time analytics.

The AMG Energy Group subsidiary was created to be the technology arm of the Company.  AMG centers on the licensing of Alliance BioEnergy Plus’s Intellectual Property (IP), engineering and construction of CTS plants and developing technologies in the renewable energy, bio-fuels and new technology sectors. 

The CTS Cellulose Ethanol technology can produce a high quality, clean burning Ethanol from almost any plant material less expensively, faster, and without any hazardous inputs. Alliance BioEnergy Plus has completed the construction of its commercial scale CTS demonstration plant and research laboratories at its subsidiary Central Florida Institute of Science and Technology, Inc. (CFIST).

This past March, Alliance Bio-Products, Inc., a subsidiary of Alliance BioEnergy Plus, announced its filing of a Regulation D (506(c)) offering with the U.S. Securities and Exchange Commission (SEC). The purpose of the filing is to secure funds via accredited investors for the purchase of a bioethanol plant in Southeast Florida that would enable the Company to boost production capacity and profitability of its sustainable, environmentally friendly alternative to petroleum-based fuels and other products through its patented CTS conversion process.

In April, Alliance Bio-Products announced that it entered into an option agreement with the Indian River County solid waste disposal district for the securement of its processed vegetative waste. The option agreement will continue to be upheld under the condition that Alliance Bio-Products secures a South Florida biofuel plant within 180 days of the signing. The option agreement was completed in early February 2017. Upon the Option being exercised, Indian River County and Alliance Bio-Products will enter into a final contract.

With this agreement, Alliance Bio-Products will be granted the exclusive right and option to a portion of the county's processed vegetative waste. This includes yard and agricultural waste. The Option will enable the county to deliver waste to the Alliance BioEnergy plant without a fee, making the disposal service free of charge to the county while providing Alliance with a no-cost feedstock.

Alliance BioEnergy Plus, Inc. (ALLM), closed Monday's trading session at $0.16, even for the day, on 31,450 volume with 4 trades. The average volume for the last 60 days is 34,253 and the stock's 52-week low/high is $0.10/$0.44.

Lithium Corp. (LTUM)

SmarTrend Newsletters, FNNO Newsletters, AllPennyStocks, Breaking Bulls, OTCPicks, Stockpalooza, Canadian Microcap Report, PickPennyStocks, and Stockdigest Report reported on Lithium Corp. (LTUM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lithium Corp. engages in the identification, acquisition, and exploration of metals and minerals with a focus on lithium mineralization on properties in Nevada. The Company’s commitment is to the exploration for energy storage related resources across North America, looking to capitalize on opportunities within the growing next generation energy storage markets. An exploration stage mining enterprise, Lithium has its headquarters in Elko, Nevada.

The Company’s flagship property is Fish Lake Valley. At Fish Lake Valley, it holds Placer claims that cover roughly 7,800 acres. The Fish Lake Valley Property is in northern Esmeralda county in west-central Nevada.

Lithium also has its Hughes Property in Tonopah, Nevada. Lithco participated in the creation of Summa LLC, a private Nevada Limited Liability company, which holds 88 fee-title patented lode claims, which cover about 1,191.3 acres of prospective mineral lands. Lithium signed a Joint Operating Agreement with the other participants to govern the conduct of Summa, and the development of the lands.

In northwestern Nevada, Washoe County, Lithium has its San Emidio Project. It staked a block of claims in the San Emidio Valley during September of 2011, and presently holds 1,600 acres. The Company also has its North Big Smokey lithium brine exploration property in Big Smokey Valley, Nye County, Nevada. The property is on federal lands. It consists of 44 association placer claims, most which are 80 acres.  In total the prospect is approximately 3400 acres. 

In Shuswap, B.C., the Company has its BC Sugar Property. It has assembled a 19,816-acre (8,019 hectare) block of mineral claims in B.C. that is highly prospective for hosting commercially extractable deposits of flake graphite.

In September 2016, Lithium announced that it staked a block of claims on the Buena Vista lithium-in-brine prospect in Pershing County, Nevada, totaling about 8,000 acres. In October 2016, the Company announced that it jointly staked with Idaho North Resources, Inc. (IDAH) a block of claims on the Gabbs Valley playa in Mineral County, Nevada totaling about 4,790 acres.

This past February, Lithium announced that it signed a Letter of Intent (LOI) on the Salt Wells lithium-in-brine prospect in Churchill County Nevada. With this agreement, Nevada Sunrise Gold Corp. (NVSGF) may earn a 100 percent interest in the property subject to a 2 percent Net Smelter Royalty (NSR) by making staged payments of cash and shares over the next two years.

Last month, Lithium announced that it and Bormal Resources, Inc. (a private B.C. company) executed the formal agreement concerning the optioning of three Tantalum-Niobium properties in B.C. Additionally, the Company amended its trenching permit for the BC Sugar flake graphite property, to allow for work in an earlier untested area.

Lithium Corp. (LTUM), closed Monday's trading session at $0.0649, up 8.17%, on 110,437 volume with 19 trades. The average volume for the last 60 days is 176,759 and the stock's 52-week low/high is $0.0512/$0.12.

Jones Soda Co. (JSDA)

SmallCapVoice, Actual Gains, PennyStockRumors.net, PricelessPennyStocks, SmarTrend Newsletters, Stock Analyzer, SuperNova Elite, Wealthpire Inc., Investor Update, TopStockAnalysts, and Dividend Opportunities reported on Jones Soda Co. (JSDA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Jones Soda Co. is a leader in the premium soda category. The Company is known for its innovative flavors and branding. Jones Soda markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, Jones Stripped™ and Lemoncocco™ brands. Jones Soda sells throughout North America in glass bottles, cans and on fountain via traditional beverage outlets, restaurants, as well as alternative accounts. Jones Soda is headquartered in Seattle, Washington.

Jones Soda is made with pure cane sugar. The Company’s varied product line includes pure cane sugar soda, zero-calorie soda, and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar. Jones Soda also sells Jones Gear (clothing items) and Jones Candy.

Jones Soda has its natural soda line - Jones Stripped. Natural Jones Soda launched in California during 2013 to meet the increasing demand for healthier beverage options and to expand the Jones product portfolio. Jones Stripped is sweetened with a blend of natural sweeteners. These include pure cane sugar, organic agave syrup, and stevia.

Jones Beverages International, a subsidiary of Jones Soda, has its premium non-carbonated blended beverage brand - Lemoncocco™. This product is flavored with the extracts of Sicilian lemons and a bit of coconut cream. Lemoncocco™ is a natural beverage, lightly sweetened with a little cane sugar. It is 90 calories per 12 ounce serving, and is dairy free and gluten free.

7-Eleven, Inc. and Jones Soda have partnered and created 7-Select® brand premium sodas crafted by Jones, the first premium carbonated beverage in the 7-Select private brand lineup. Each 7-Select premium soda is made with natural flavors, lightly sweetened with cane sugar, and ranges from only 180 to 195 calories per 20-ounce bottle. Furthermore, this brand includes 75 mg. of caffeine in each serving.

Last month, Jones Soda announced that Green Apple Cane Sugar Soda will be available as part of the BIG GULP® program at roughly 400 Pacific Northwest 7-Eleven stores.

Ms. Jennifer Cue, Jones Soda Chief Executive Officer, said, “Every day we are seeing more interest and validation of Jones Soda as a fountain alternative to other mainstream brands. This is an amazing opportunity to extend our collaboration with 7-Eleven while reaching a broader demographic. So treat yourself to a Jones in a different way, as our classic Green Apple Cane Sugar Soda will now be available on fountain in the Northwest.”

Jones Soda Co. (JSDA), closed Monday's trading session at $0.51, up 0.39%, on 64,811 volume with 29 trades. The average volume for the last 60 days is 57,531 and the stock's 52-week low/high is $0.33/$0.70.

FreeSeas, Inc. (FREEF)

We are reporting on FreeSeas, Inc. (FREEF) today, here at the QualityStocks Daily Newsletter.

FreeSeas, Inc. is a transporter of dry-bulk cargoes through the ownership and operation of Handysize vessels. In addition, the Company is an owner of a controlling stake in a company commercially operating tankers and dry-bulkers. FreeSeas, by way of its subsidiaries, provides drybulk shipping services. The Company is a top, international commercial shipping enterprise transporting iron ore, coal, grain, steel products and other drybulk cargoes along global shipping routes. Incorporated in the Marshall Islands, FreeSeas is headquartered in Athens, Greece. The Company lists on the OTC Markets Group’s OTCQB.

FreeSeas operates two Handysize vessels. The Company said that its investment and operational emphasis has been in the Handysize sector (usually defined as less than 40,000 dwt (deadweight tonnage) of carrying capacity) and the Handymax sector (usually defined as between 40,000 dwt and 60,000 dwt).

FreeSeas believes Handysize and Handymax vessels are more versatile in the kinds of cargoes they can carry and trade routes they can follow, and offer less volatile returns than larger vessel classes. Furthermore, FreeSeas believes this segment offers better demand and supply demographics than other drybulk asset classes.

FreeSeas (under spot charters) pays voyage expenses. These expenses include port, canal, and fuel costs.  Under period time charters, the “charterer” pays the voyage expenses. Under spot charters and period time charters, FreeSeas is responsible for vessel operating expenses. These expenses include crew costs, provisions, deck and engine stores, lubricating oil, insurance, maintenance, and also repairs.

Additionally, FreeSeas is responsible for each vessel's intermediate drydocking and special survey costs. The exception to this practice is called a "bareboat contract". This is where the charterer is responsible for the vessel's maintenance and operations, and all voyage expenses.

This past February, FreeSeas announced that its Amended and Restated Articles of Incorporation were amended to effect a reverse stock split of FreeSeas’ issued and outstanding common stock at a ratio of one new share for every 5,000 shares that were outstanding. The reverse stock split consolidates 5,000 shares of common stock into one share of common stock at a par value of $0.001 per share.

FreeSeas, Inc. (FREEF), closed Monday's trading session at $0.0068, down 13.92%, on 3,615,066 volume with 70 trades. The average volume for the last 60 days is 1,417,124 and the stock's 52-week low/high is $0.0031/$1.39.

Ascent Solar Technologies, Inc. (ASTI)

Profitable Trader Authority, Promotion Stock Secrets, StreetInsider, PennyPro, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Preacher, Beacon Equity Research, Penny Stocks Finder, InvestorsUnderground, and Stockgoodies reported earlier on Ascent Solar Technologies, Inc. (ASTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ascent Solar Technologies, Inc. is a developer and manufacturer of state-of-the-art, flexible, thin-film photovoltaic (PV) modules integrated into its EnerPlex™ series of consumer products. The OTCQB-listed Company is a developer of award-winning thin-film photovoltaic modules with substrate materials that are more flexible, versatile, and stronger than traditional solar panels.

EnerPlex is Ascent Solar Technologies’ brand of consumer products. EnerPlex is a division of Ascent Solar. Ascent Solar’s Research and Development (R&D) and its 30 MW nameplate production facility is in Thornton, Colorado. The Company's quality management system has attained ISO 9001:2015 certification.

Ascent Solar’s technology is thin-film CIGS on flexible, plastic substrate. The Company’s manufacturing is roll-to-roll manufacturing, monolithic integration & intelligent process control. Its business divisions are: Solar Solutions - Aerospace, UAVs, Military, Specialty Applications, Consumer Market & Transportation; and
Power Storage Solutions - Mobility, Outdoor & Emergency Portable Power.

Ascent Solar Technologies’ flexible, lightweight CIGS modules enable seamless integration of solar power into an unlimited number of applications without the restrictions of normal glass panels. Its modules can be directly integrated into consumer products and off-grid applications. In addition, they can be directly integrated into aerospace and building integrated applications.

Recently, Ascent Solar Technologies announced that it signed an Intellectual Property (IP) Disposal Agreement and other collaboration agreements with its existing battery product vendor, Sun Pleasure Co. Ltd (SPCL) concerning the transfer of Ascent's proprietary owned EnerPlex™ consumer brand name, to better allocate its resources and to continue to center on its core strength in the high-value specialty PV market.

With these agreements, the Company will transfer its IP related to the EnerPlex™ brand, which includes trademarks, website domains, non-solar components of product designs and patents (non-solar IP) to SPCL for a consideration of approximately $1.33M. Following the transfer, Ascent Solar Technologies will no longer produce or sell Enerplex-branded consumer products.

Ascent Solar Technologies, Inc. (ASTI), closed Monday's trading session at $0.0005, down 16.67%, on 402,771,530 volume with 262 trades. The average volume for the last 60 days is 101,772,111 and the stock's 52-week low/high is $0.0005/$1.06.

graphic

The QualityStocks
Company Corner

graphic
graphic

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.156, up 3.24%, on 946,679 volume with 353 trades. The stock’s average daily volume over the past 60 days is 38,442, and its 52-week low/high is $0.1197/$0.59.

Kootenay Zinc Corp. today provided an update on exploration activities at its Sully project. Field programs have commenced with the arrival of excellent weather conditions and the project team is currently undertaking a number of activities at the site, including, at the East anomalies: a drill campaign at E1, detailed gravity surveying of E2, E3 and E4, prospecting and mapping, and access reconnaissance for planned drilling at E3; and new gravity surveying at the WEST anomaly.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Kootenay Zinc Corp.: Sully Project Exploration Update

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is “One to Watch”

Kootenay Zinc Corp.: Sully Project Geophysical, Permitting and Drilling Update

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.42, up 5.00%, on 504,690 volume with 267 trades. The stock’s average daily volume over the past 60 days is 1,172,916, and its 52-week low/high is $0.05/$0.72.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media

InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media

NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.7299, off by 0.0037%, on 5,801 volume with 12 trades. The stock’s average daily volume over the past 60 days is 7,297, and its 52-week low/high is $1.33/$4.35.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017

Monaker Group Appoints Robert Post to Board of Directors

Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.42, off by 2.33%, on 88,873 volume with 18 trades. The stock’s average daily volume over the past 60 days is 186,970 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub (ORHB) Appoints New Chief Operating Officer to Facilitate Growth Strategies

Significant Milestone Helps ORHub (ORHB) Deliver Cost-cutting Insight to Health Care Providers

NetworkNewsWire Announces Publication on Solutions for the Health Care Industry's Data Processing Needs

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.55, even for the day. The stock’s average daily volume over the past 60 days is 3,611, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Expands Distribution with New 2017 Electrician Exam Preparation Series

ProBility Media Corp. Appoints Billy Smith to the Newly Created Vocational Advisory Board

ProBility Media Corp. Files 10Q, Reports Third Consecutive Quarter of Revenue Growth

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketClub Analysis
(INPX) +148.04%

2.

StockMarketWatch
(HOTRW) +88.53%

3.

Winston Small Cap
(NGTF) +60.87%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251